Literature DB >> 32419609

Application of flow diverters in the treatment of aneurysms in the internal carotid artery bifurcation region.

Mostafa Mahmoud1, Ahmed Farag1, Mostafa Farid1, Ahmed Elserwi1, Amr Abdelsamad1, Wessam Guergues1, Farouk Hassan2.   

Abstract

INTRODUCTION: The treatment of aneurysms in the internal carotid bifurcation region (ICABR), including aneurysms of the true internal carotid artery (ICA) terminus, those inclined on the proximal A1 or M1 segments or at the most distal pre-bifurcation (ICA) segment, is often challenging in microsurgical clipping and endovascular surgery. Few reports had discussed flow diversion as a therapeutic option for this group.
METHODS: This was a retrospective study analysing flow diversion in treating ICABR aneurysms. Seven patients harbouring eight aneurysms in the ICABR were treated with flow diversion. Five aneurysms were inclined on the proximal A1 segment, and three were located at the most distal pre-bifurcation segment. Patients' demographics, presentation, procedure technical description, angiographic and clinical follow-up were recorded. PubMed and Ovid MEDLINE were also reviewed for articles published in English, including case series or case reports, for ICABR aneurysms treated with flow diverters.
RESULTS: All patients except one underwent angiographic follow-up. The Karman-Byrne occlusion scale was used to determine the occlusion rate. All six patients with documented angiographic follow-up had a class IV occlusion score. No permanent or transient neurological or non-neurological complications were encountered in this study.
CONCLUSION: Treating ICABR aneurysms using flow diversion is feasible, with a promising angiographic occlusion rate. Further studies are needed to analyse long-term clinical and angiographic results.

Entities:  

Keywords:  Flow diverter; ICA termination; ICA terminus; bifurcation aneurysms; proximal A1 segment

Mesh:

Substances:

Year:  2020        PMID: 32419609      PMCID: PMC7416353          DOI: 10.1177/1971400920924840

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  33 in total

1.  Characteristics of aneurysms of the internal carotid artery bifurcation.

Authors:  S Sakamoto; S Ohba; M Shibukawa; Y Kiura; T Okazaki; K Arita; K Kurisu
Journal:  Acta Neurochir (Wien)       Date:  2005-11-30       Impact factor: 2.216

2.  A Novel Configuration of Pipeline Embolization Device for Internal Carotid Bifurcation Region Aneurysms: Horizontal Deployment.

Authors:  F P Trivelato; J F S Araújo; M T Salles Rezende; A C Ulhôa
Journal:  Clin Neuroradiol       Date:  2015-06-06       Impact factor: 3.649

3.  Endothelialization following Flow Diversion for Intracranial Aneurysms: A Systematic Review.

Authors:  K Ravindran; M M Salem; A Y Alturki; A J Thomas; C S Ogilvy; J M Moore
Journal:  AJNR Am J Neuroradiol       Date:  2019-01-24       Impact factor: 3.825

Review 4.  Stent-supported aneurysm coiling: a literature survey of treatment and follow-up.

Authors:  M Shapiro; T Becske; D Sahlein; J Babb; P K Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-27       Impact factor: 3.825

5.  p64 Flow Modulation Device in the treatment of intracranial aneurysms: initial experience and technical aspects.

Authors:  Francesco Briganti; Giuseppe Leone; Mariano Marseglia; Domenico Cicala; Ferdinando Caranci; Francesco Maiuri
Journal:  J Neurointerv Surg       Date:  2015-04-20       Impact factor: 5.836

6.  Safety of the pipeline embolization device in treatment of posterior circulation aneurysms.

Authors:  T J Phillips; J D Wenderoth; C C Phatouros; H Rice; T P Singh; L Devilliers; V Wycoco; S Meckel; W McAuliffe
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-07       Impact factor: 3.825

7.  Modifying flow in the ACA-ACoA complex: endovascular treatment option for wide-neck internal carotid artery bifurcation aneurysms.

Authors:  Erez Nossek; David J Chalif; Mitchell Levine; Avi Setton
Journal:  J Neurointerv Surg       Date:  2014-04-10       Impact factor: 5.836

8.  Initial and mid-term results from 108 consecutive patients with cerebral aneurysms treated with the WEB device.

Authors:  Christin Clajus; Christoph Strasilla; Tom Fiebig; Vojtech Sychra; David Fiorella; Joachim Klisch
Journal:  J Neurointerv Surg       Date:  2016-04-13       Impact factor: 5.836

9.  Flow diversion covering the M1 origin as a last resort.

Authors:  Li-Mei Lin; Matthew T Bender; Geoffrey P Colby; Bowen Jiang; Jessica K Campos; David A Zarrin; Robert W C Young; Risheng Xu; Justin M Caplan; Judy Huang; Rafael J Tamargo; Alexander L Coon
Journal:  Stroke Vasc Neurol       Date:  2018-12-19

10.  Safety and efficacy of aneurysm treatment with WEB in the cumulative population of three prospective, multicenter series.

Authors:  Laurent Pierot; Jacques Moret; Xavier Barreau; Istvan Szikora; Denis Herbreteau; Francis Turjman; Markus Holtmannspötter; Anne-Christine Januel; Vincent Costalat; Jens Fiehler; Joachim Klisch; Jean-Yves Gauvrit; Werner Weber; Hubert Desal; Stéphane Velasco; Thomas Liebig; Luc Stockx; Joachim Berkefeld; Andrew Molyneux; James Byrne; Laurent Spelle
Journal:  J Neurointerv Surg       Date:  2017-09-30       Impact factor: 5.836

View more
  3 in total

1.  Trends of Expanding Indications of Woven EndoBridge Devices for the Treatment of Intracranial Aneurysms: A Systematic Review and Meta-analysis.

Authors:  Ki Baek Lee; Chong Hyun Suh; Yunsun Song; Boseong Kwon; Mi Hyeon Kim; Jong-Tae Yoon; Deok Hee Lee
Journal:  Clin Neuroradiol       Date:  2022-08-29       Impact factor: 3.156

2.  Flared non-flow diverting ends of the FRED flow diverter for cerebral aneurysms facilitate device anchoring at the arterial bifurcation.

Authors:  Jan-Karl Burkhardt; Laura Stone McGuire; Christoph J Griessenauer
Journal:  Neuroradiol J       Date:  2021-05-04

Review 3.  Hydrophilic polymer embolization following flow diversion of cerebral aneurysms.

Authors:  Mohamad Abdalkader; Anvitha Sathya; Alice Ma; Anna M Cervantes-Arslanian; David Y Chung; Glenn Barest; Thanh N Nguyen
Journal:  Neuroradiol J       Date:  2021-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.